Clinical Trials Directory

Trials / Unknown

UnknownNCT02029183

Screening and Treatment of SAHS in Patients With Acute Ischemic Stroke

Screening and Treatment of in Sleep Apnea Hypopnea Syndrome(SAHS)Patients With Acute Ischemic Stroke

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Peking University · Academic / Other
Sex
All
Age
35 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Ischemic stroke is a kind of common disease with great harm. In acute stage of stroke there is sharply increasing morbidity of sleep apnea hypopnea syndrome. Our suppose that treatment with noninvasive ventilation for patients with acute ischemic stroke should improve the functional prognosis(measuring with 90d modified Rankin score).

Detailed description

In acute state of ischemic stroke,if patients with sleep apnea hypopnea syndrome may need additional respiratory management such bi-level positive airway pressure.We supposed the patients with stroke can take benefit of functional recovery form bi-level positive airway pressure. We choose the patients who suffered ischemic stroke in 48 hours ,then evaluate the respiratory status. Stroke patients who were diagnosed as sleep apnea hypopnea syndrome will accept additional treatment with bi-level positive airway pressure for 7 night(per night 6 hours).Then the modified Rankin scale score and NIHSS will be recorded at 30 days and 90 days after stroke.

Conditions

Interventions

TypeNameDescription
DEVICEBi level positive pressure ventilationBi level positive pressure ventilation should be given for subject for 6 hours per night ,total 7 times.
DEVICEbi-level positive airway pressure

Timeline

Start date
2013-12-01
Primary completion
2016-12-01
Completion
2017-05-01
First posted
2014-01-07
Last updated
2014-01-07

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02029183. Inclusion in this directory is not an endorsement.